Red Hoffman from Manas AI earns $ 24.6 million, a small part of other startups to discover drugs AI

LinkedIn founder Red Hoffman and Sidhartha Mukherji, Cancer Researcher and author of “Emperor of all diseases”, participated in establishing a drug discovery company that works in Amnesty International, Manas AI. The company, which will initially focus on breast cancer, prostate cancer and lymphoma, raised $ 24.6 million of Hoffman’s seed financing, General Kumalst, and Giriok.

The capital from Manas AI is diminished compared to some other startups trying to use artificial intelligence models to develop new drugs. Last year, Xaira, which she claimed was ready to start drug development, was launched with a Huge 1 billion dollars In initial financing. Treeline Biosciencees is another company that uses artificial intelligence to discover drugs and raised $ 422 million last year, I reported indpts.

Manas AI claims that she will desigate molecules with artificial intelligence, then test them in a wet laboratory, According to Hoffman, Hoffman said During the presentation of his new book “Superagence“The outfit also He says The cloud computing platform of Microsoft, Azure and Microsoft will use “AI’s deep knowledge” to develop new drugs.

Hoffman has close relationships with Microsoft, which has acquired his former company, LinkedIn, in a Wonderful deal In 2016.